Skip to main content
Clinical Trials/CTRI/2020/11/028826
CTRI/2020/11/028826Active, not recruiting未知

Effect of anaesthetic agents on immuno-inflammatory response of breast cancer

Chittaranjan National Cancer Institute0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Active, not recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Newly diagnosed breast cancer (Unilateral) confirmed with histopathological diagnosis. 2. ASA I (Normal healthy patient) & ASA II (Patient with mild systemic disease)
  • 3. T1 N0, T2N0, T3N0, T1N1, T2N1, T3N1 Mx
  • 4. Both male & female
  • 6. Duration of surgery <= to 2 hrs.

Exclusion Criteria

  • 1. Patient having any kind of anticancer treatment
  • 2. Active bleeding
  • 3. Recent history of massive blood transfusion
  • 4. Pregnant & Lactating woman

Investigators

Similar Trials

Effects of Anaesthesia On Immune... | Clinical Trial